Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines


US FDA stem cell enforcement challenged by state legislation

State legislation allowing unapproved stem cell treatments could undermine efforts by the US FDA to clampdown on unregistered clinics.

ChromaTan to develop continuous purification tech with $2.5m US FDA grant

ChromaTan will develop an integrated and continuous downstream purification platform through provisions in the 21st Century Cures Act to support manufacturing initiatives.

EU distribution: BioCat on board the Vmax Express

SGI-DNA has selected BioCat to distribute its protein expression platform Vmax Express, which it says is more rapid than traditional expression systems.

Fire ant venom to combat thick skin

Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.

Brammer ups early phase manufacturing capacity

Brammer Bio has doubled its early phase manufacturing capacity at its Alachua, Florida-based site.

Catalent to buy Cook Pharmica for $950m in cash

Catalent Inc has announced it will buy Cook Pharmica for $950m in cash to boost its high tech drug production business.

Samsung Bioepis will use CMOs to make Ontruzant if it is approved

Samsung Bioepis will use contractors to make its candidate Herceptin biosimilar Ontruzant if it goes on to be approved in Europe.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...